These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25250647)

  • 1. Effect of N-acetylcysteine pretreatment of deceased organ donors on renal allograft function: a randomized controlled trial.
    Orban JC; Quintard H; Cassuto E; Jambou P; Samat-Long C; Ichai C
    Transplantation; 2015 Apr; 99(4):746-53. PubMed ID: 25250647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cyclosporine A pretreatment of deceased organ donors on kidney graft function (Cis-A-rein): study protocol for a randomized controlled trial.
    Orban JC; Fontaine E; Cassuto E; Baumstarck K; Leone M; Constantin JM; Ichai C;
    Trials; 2018 Apr; 19(1):231. PubMed ID: 29665840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Delayed Graft Function on the Outcome and Allograft Survival of Kidney Transplanted Patients from a Deceased Donor.
    Maia LF; Lasmar MF; Fabreti-Oliveira RA; Nascimento E
    Transplant Proc; 2021 Jun; 53(5):1470-1476. PubMed ID: 34006380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of N-acetyl cysteine and vitamin C on kidney allograft function biomarkers interleukin-18 and neutrophil gelatinase-associated lipocalin.
    Sahraei Z; Salamzadeh J; Nafar M
    Iran J Kidney Dis; 2015 Jan; 9(1):56-62. PubMed ID: 25599738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase I/II, double-blind, placebo-controlled study assessing safety and efficacy of C1 esterase inhibitor for prevention of delayed graft function in deceased donor kidney transplant recipients.
    Jordan SC; Choi J; Aubert O; Haas M; Loupy A; Huang E; Peng A; Kim I; Louie S; Ammerman N; Najjar R; Puliyanda D; Vo A
    Am J Transplant; 2018 Dec; 18(12):2955-2964. PubMed ID: 29637714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed graft function does not harm the future of donation-after-cardiac death in kidney transplantation.
    Le Dinh H; Weekers L; Bonvoisin C; Krzesinski JM; Monard J; de Roover A; Squifflet JP; Meurisse M; Detry O
    Transplant Proc; 2012 Nov; 44(9):2795-802. PubMed ID: 23146527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-acetylcysteine decreases urinary level of neutrophil gelatinase-associated lipocalin in deceased-donor renal transplant recipients: a randomized clinical trial.
    Modarresi A; Nafar M; Sahraei Z; Salamzadeh J; Chaibakhsh S; Ziaie S; Parvin M; Panahi Y; Einollahi B
    Biomarkers; 2018 Sep; 23(6):589-596. PubMed ID: 29683755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of delayed graft function and wound healing complications after deceased-donor kidney transplantation is not affected by de novo everolimus.
    Albano L; Berthoux F; Moal MC; Rostaing L; Legendre C; Genin R; Toupance O; Moulin B; Merville P; Rerolle JP; Bayle F; Westeel PF; Glotz D; Kossari N; Lefrançois N; Charpentier B; Blanc AS; Di Giambattista F; Dantal J;
    Transplantation; 2009 Jul; 88(1):69-76. PubMed ID: 19584683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validating Early Post-Transplant Outcomes Reported for Recipients of Deceased Donor Kidney Transplants.
    Potluri VS; Parikh CR; Hall IE; Ficek J; Doshi MD; Butrymowicz I; Weng FL; Schröppel B; Thiessen-Philbrook H; Reese PP
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):324-31. PubMed ID: 26668026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-Year Outcomes of a Randomized, Double-Blind, Placebo-Controlled Study Assessing Safety and Efficacy of C1 Esterase Inhibitor for Prevention of Delayed Graft Function in Deceased Donor Kidney Transplant Recipients.
    Huang E; Vo A; Choi J; Ammerman N; Lim K; Sethi S; Kim I; Kumar S; Najjar R; Peng A; Jordan SC
    Clin J Am Soc Nephrol; 2020 Jan; 15(1):109-116. PubMed ID: 31843975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of kidney transplant outcome based on different DGF definitions in Chinese deceased donation.
    Hu XJ; Zheng J; Li Y; Tian XH; Tian PX; Xiang HL; Pan XM; Ding CG; Ding XM; Xue WJ
    BMC Nephrol; 2019 Nov; 20(1):409. PubMed ID: 31722677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed Graft Function Phenotypes and 12-Month Kidney Transplant Outcomes.
    Hall IE; Reese PP; Doshi MD; Weng FL; Schröppel B; Asch WS; Ficek J; Thiessen-Philbrook H; Parikh CR
    Transplantation; 2017 Aug; 101(8):1913-1923. PubMed ID: 27495761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-transplant HLA Antibodies and Delayed Graft Function in the Current Era of Kidney Transplantation.
    Morath C; Döhler B; Kälble F; Pego da Silva L; Echterdiek F; Schwenger V; Živčić-Ćosić S; Katalinić N; Kuypers D; Benöhr P; Haubitz M; Ziemann M; Nitschke M; Emmerich F; Pisarski P; Karakizlis H; Weimer R; Ruhenstroth A; Scherer S; Tran TH; Mehrabi A; Zeier M; Süsal C
    Front Immunol; 2020; 11():1886. PubMed ID: 32983110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors and consequences of delayed graft function.
    Ounissi M; Cherif M; Abdallah TB; Bacha M; Hedri H; Abderrahim E; Goucha R; Kheder A; Slama RB; Derouiche A; Chebil M; Bardi R; Sfar I; Gorgi Y
    Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):243-6. PubMed ID: 23538345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P-NGAL Day 1 predicts early but not one year graft function following deceased donor kidney transplantation - The CONTEXT study.
    Nielsen MB; Krogstrup NV; Nieuwenhuijs-Moeke GJ; Oltean M; Dor FJMF; Jespersen B; Birn H
    PLoS One; 2019; 14(2):e0212676. PubMed ID: 30817778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid pretreatment of organ donors to prevent postischemic renal allograft failure: a randomized, controlled trial.
    Kainz A; Wilflingseder J; Mitterbauer C; Haller M; Burghuber C; Perco P; Langer RM; Heinze G; Oberbauer R
    Ann Intern Med; 2010 Aug; 153(4):222-30. PubMed ID: 20713790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective Effects of L-Carnitine Against Delayed Graft Function in Kidney Transplant Recipients: A Pilot, Randomized, Double-Blinded, Placebo-Controlled Clinical Trial.
    Jafari A; Khatami MR; Dashti-Khavidaki S; Lessan-Pezeshki M; Abdollahi A; Moghaddas A
    J Ren Nutr; 2017 Mar; 27(2):113-126. PubMed ID: 28065453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recipient and donor body mass index as important risk factors for delayed kidney graft function.
    Weissenbacher A; Jara M; Ulmer H; Biebl M; Bösmüller C; Schneeberger S; Mayer G; Pratschke J; Öllinger R
    Transplantation; 2012 Mar; 93(5):524-9. PubMed ID: 22362367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prediction model of delayed graft function in deceased donor for renal transplant: a multi-center study from China.
    Xue W; Wang C; Chen J; Sun X; Wu X; Peng L; Chen Z; Qu Q; Zhang X; Fu Y; Dong Z; Chen Z; Feng G; Lin T; Men T; Yu L; Sun Q; Zhao Y; Zhou J; Zeng L; Zhao M; Tan J; Ye Q; Shi B; Ming Y; Zhu T; Sui W; Huang C; Fu Y
    Ren Fail; 2021 Dec; 43(1):520-529. PubMed ID: 33719820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasopressor selection during critical care management of brain dead organ donors and the effects on kidney graft function.
    Swanson EA; Patel MS; Groat T; Jameson NE; Ellis MKM; Hutchens MP; Niemann CU; Malinoski DJ; Sally MB
    J Trauma Acute Care Surg; 2020 Jun; 88(6):783-788. PubMed ID: 32459446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.